Icon Cancer Foundation (ICF) is the research partner for the Icon Group. ICF conducts Phase I-IV trials across haematology, medical oncology and radiation oncology and is involved in both national and international trials. A portion of our trials are sponsored by the pharmaceutical industry while others are driven by ICF doctors and nurses. We also participate in collaborative group studies and contribute to national registries for various cancer types. Currently, ICF conducts clinical trials across Queensland, including regional areas, with the support of our partner organisations Icon Cancer Care and Radiation Oncology Centres [ROC]. ICF is continually expanding and will soon offer clinical trials in NSW and Western Australia. We have commenced the management of radiation oncology research in to Victoria. As a not-for-profit organisation, ICF relies on a combination of funding sources, including donations, to contribute towards the costs of our collaborative group trials and investigator supported research. Donations also help us provide support to our patients who might not otherwise be able to participate in clinical trials.